THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.243-244
Main Authors: Burney, C.N., Robinson, S., Boumendil, A., Finel, H., Khvedelidze, I., Hunter, H., Poire, X., Lioure, B., Peggs, K., Foa, R., Pillai, S., Meerten, T., Bargay Lleonart, J., Schmid, C., Vergote, V., Ganser, A., Castagna, L., Mufti, G., Montoto, S.
Format: Article
Language:English
Subjects:
Immunotherapy
Lymphoma
Mantle cell lymphoma
Targeted cancer therapy
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.53_2630